In patients with cystic fibrosis, treatment with elexacaftor-tezacaftor-ivacaftor significantly improves glycemic control with no new safety concerns.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/triple-therapy-boosts-glycemic-control-cystic-fibrosis-2025a1000n2d?src=rss
Author :
Publish date : 2025-09-02 11:18:00
Copyright for syndicated content belongs to the linked Source.
